Companies in this Group

Genius Biotherapeutics (Genius)

(Bioclones (Pty) Ltd)

Established in 1982, Genius is arguably the oldest health care biotechnology company in South Africa, if not the African continent, with a track record of investing in research and development work that led to successfully commercialising South Africa’s first biosimilar product, Repotin, a recombinant human hormone known as Erythropoietin (EPO).

Genius focuses on health care applications and more specifically on the production of biopharmaceutical products. Biopharmaceutical products include such therapeutics as hormones, protein-based drugs and antibodies.

Genius is a research and development biopharmaceutical group of companies which includes the following operational business units:

  • Immunotherapy dendritic cell vaccine (DCV) technology
  • EPO production, registered as Repotin
  • Granulocyte-colony stimulating factor (G-CSF) product development
  • Integrated Bioworks (IBW) reagents